Ledger.Open graph →

SEC Form D · filed July 14, 2015

Ballantyne Therapeutics, Inc

Offering

$500K

Sold

$400K

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

CHARLOTTE, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Michael Roberts · Charlotte, NCExec · Director Simon Pedder · Charlotte, NCDirector Robert Coneybeer · Boston, MAExec · Director John S. Dwyer · Boston, MADirector Sarena D. Burch · Cayce, SCExec · Director Maceo K. Sloan · Cayce, SCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗